Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...

Boston Scientific (NYSE:BSX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday. Several other research analysts also ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted ...

The Express® LD iliac premounted stent system (Boston Scientific, MA, USA) is currently the only available premounted balloon-expandable stent that is approved by the US FDA for the treatment of ...

Continuing its acquisition streak into 2025, Marlborough-based medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

Plans to buy Bolt Medical, Inc., a developer of intravascular lithotripsy equipment for treating hardened coronary and peripheral artery disease, were announced by Boston Scientific Corporation ...